(TNS) — A Chinese company is one of several being targeted by federal legislators.

The company — which has a location in Pennsylvania — has been called a “national security threat” by one of two bills attempting to crack down on specific Chinese companies.

The Philadelphia Inquirer reports how WuXi AppTec — which, according to its website, is a Shanghai-based biotechnology company with “operations across Asia, Europe, and North America” — is among four companies targeted by legislation advancing in Congress.

In fact, there are two bills of this nature currently passing through: One is “The Prohibiting Foreign Access to American Genetic Information Act of 2024,” which the Homeland Security website explains “would ban all biotechnology companies that are owned or controlled by a foreign adversary, such as the Chinese Communist Party (CCP), and whose business practices threaten national security, from receiving U.S. taxpayer dollars through federal contracts, grants, and loans.”

The other — a House bill called the Biosecure Act — would also “[prohibit] federal contraction with certain biotechnology providers connected to foreign adversaries,” and directly calls WuXi AppTec “a risk to U.S. national security based on specified activities.”

You can listen to this story — along with other important stories concerning Pennsylvania — on the “Today in Pa.” episode below:

The Financial Times continues to report how the main concern of these officials is that the company is sharing the genetic and personal health information of Americans through their relationship with U.S.-based companies.

WuXi, for example, has a campus in Philadelphia’s Navy Yard, and even has contracts with the University of Pennsylvania. In fact, it has a “significant ties” to cell and gene companies in Philadelphia, according to the Inquirer.

Its other partners, adds the Financial Times, include Pfizer and Eli Lilly.

Both bills are still waiting upon further approval.